Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 5534

1.

Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis.

Balázs A, Mall MA.

Front Pharmacol. 2018 Oct 1;9:1112. doi: 10.3389/fphar.2018.01112. eCollection 2018. Review.

PMID:
30327603
2.

Association Between SLC30A8 rs13266634 Polymorphism and Risk of T2DM and IGR in Chinese Population: A Systematic Review and Meta-Analysis.

Dong F, Zhang BH, Zheng SL, Huang XX, Du XB, Zhu KH, Chen XJ, Wu J, Liu DD, Wen ZH, Zou XQ, Liu YM, Dong SR, Zeng FF, Yang G, Jing CX.

Front Endocrinol (Lausanne). 2018 Sep 25;9:564. doi: 10.3389/fendo.2018.00564. eCollection 2018.

3.

Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.

Yang Y, Wang M, Liu B.

J Cell Physiol. 2018 Oct 14. doi: 10.1002/jcp.27240. [Epub ahead of print]

PMID:
30317601
4.

Successful azathioprine treatment in an adolescent with chronic enteropathy associated with SLCO2A1 gene: A case report.

Eda K, Mizuochi T, Takaki Y, Ushijima K, Umeno J, Yamashita Y.

Medicine (Baltimore). 2018 Oct;97(41):e12811. doi: 10.1097/MD.0000000000012811.

5.

Characterization of hemostasis in mice lacking the novel thrombosis susceptibility gene Slc44a2.

Tilburg J, Adili R, Nair TS, Hawley ME, Tuk DC, Jackson M, Spronk HM, Versteeg HH, Carey TE, van Vlijmen BJM, Maracle CX, Holinstat M.

Thromb Res. 2018 Sep 26;171:155-159. doi: 10.1016/j.thromres.2018.09.057. [Epub ahead of print]

PMID:
30312801
6.

Difference of molecular alterations in HER2-positive and HER2-negative gastric cancers by whole-genome sequencing analysis.

Zhou C, Feng X, Yuan F, Ji J, Shi M, Yu Y, Zhu Z, Zhang J.

Cancer Manag Res. 2018 Sep 26;10:3945-3954. doi: 10.2147/CMAR.S172710. eCollection 2018.

7.

Hyperammonemia in Hepatic Encephalopathy.

Jayakumar AR, Norenberg MD.

J Clin Exp Hepatol. 2018 Sep;8(3):272-280. doi: 10.1016/j.jceh.2018.06.007. Epub 2018 Jun 20. Review.

PMID:
30302044
8.

A Membrane Transporter Is Required for Steroid Hormone Uptake in Drosophila.

Okamoto N, Viswanatha R, Bittar R, Li Z, Haga-Yamanaka S, Perrimon N, Yamanaka N.

Dev Cell. 2018 Oct 1. pii: S1534-5807(18)30741-X. doi: 10.1016/j.devcel.2018.09.012. [Epub ahead of print]

PMID:
30293839
9.

Functional analysis of a triplet deletion in the gene encoding the sodium glucose transporter 3, a potential risk factor for ADHD.

Schäfer N, Friedrich M, Jørgensen ME, Kollert S, Koepsell H, Wischmeyer E, Lesch KP, Geiger D, Döring F.

PLoS One. 2018 Oct 4;13(10):e0205109. doi: 10.1371/journal.pone.0205109. eCollection 2018.

10.

Combination Metabolomics Approach for Identifying Endogenous Substrates of Carnitine/Organic Cation Transporter OCTN1.

Masuo Y, Ohba Y, Yamada K, Al-Shammari AH, Seba N, Nakamichi N, Ogihara T, Kunishima M, Kato Y.

Pharm Res. 2018 Oct 2;35(11):224. doi: 10.1007/s11095-018-2507-1.

PMID:
30280275
11.

Estrogen Receptor 1 (ESR1) Enhances Slc2a4/GLUT4 Expression by a SP1 Cooperative Mechanism.

Barreto-Andrade JN, de Fátima LA, Campello RS, Guedes JAC, de Freitas HS, Machado MMOUF.

Int J Med Sci. 2018 Aug 10;15(12):1320-1328. doi: 10.7150/ijms.26774. eCollection 2018.

12.

SLC2A5 overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemia.

Zhao P, Huang J, Zhang D, Zhang D, Wang F, Qu Y, Guo T, Qin Y, Wei J, Niu T, Zheng Y.

Br J Haematol. 2018 Sep 11. doi: 10.1111/bjh.15580. [Epub ahead of print]

PMID:
30272826
13.

Subcellular drug distribution: mechanisms and roles in drug efficacy, toxicity, resistance, and targeted delivery.

Li Q, Zhou T, Wu F, Li N, Wang R, Zhao Q, Ma YM, Zhang JQ, Ma BL.

Drug Metab Rev. 2018 Sep 29:1-18. doi: 10.1080/03602532.2018.1512614. [Epub ahead of print]

PMID:
30270675
15.

Diabetes Modulates MicroRNAs 29b-3p, 29c-3p, 199a-5p and 532-3p Expression in Muscle: Possible Role in GLUT4 and HK2 Repression.

Esteves JV, Yonamine CY, Pinto-Junior DC, Gerlinger-Romero F, Enguita FJ, Machado UF.

Front Endocrinol (Lausanne). 2018 Sep 12;9:536. doi: 10.3389/fendo.2018.00536. eCollection 2018.

16.

Physiology and Pathophysiology of Steroid Biosynthesis, Transport and Metabolism in the Human Placenta.

Chatuphonprasert W, Jarukamjorn K, Ellinger I.

Front Pharmacol. 2018 Sep 12;9:1027. doi: 10.3389/fphar.2018.01027. eCollection 2018. Review.

17.

Targeting endosomal pH for cancer chemotherapy.

Lucien F, Lavoie RR, Dubois CM.

Mol Cell Oncol. 2018 Mar 13;5(3):e1435184. doi: 10.1080/23723556.2018.1435184. eCollection 2018.

PMID:
30250892
18.

SLC6A1-miR133a-CDX2 loop regulates SK-OV-3 ovarian cancer cell proliferation, migration and invasion.

Zhao Y, Zhou X, He Y, Liao C.

Oncol Lett. 2018 Oct;16(4):4977-4983. doi: 10.3892/ol.2018.9273. Epub 2018 Aug 7.

19.

The molecular mechanism of SLC34 proteins: insights from two decades of transport assays and structure-function studies.

Forster IC.

Pflugers Arch. 2018 Sep 22. doi: 10.1007/s00424-018-2207-z. [Epub ahead of print] Review.

PMID:
30244375
20.

The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.

Zhang Y, Zhang Y, Sun K, Meng Z, Chen L.

J Mol Cell Biol. 2018 Sep 18. doi: 10.1093/jmcb/mjy052. [Epub ahead of print]

PMID:
30239845

Supplemental Content

Loading ...
Support Center